These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32266248)

  • 41. Hydrogels in ophthalmic applications.
    Kirchhof S; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Rupenthal ID
    Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies for Improving Ocular Drug Bioavailability and Corneal Wound Healing with Chitosan-Based Delivery Systems.
    Irimia T; Ghica MV; Popa L; Anuţa V; Arsene AL; Dinu-Pîrvu CE
    Polymers (Basel); 2018 Nov; 10(11):. PubMed ID: 30961146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanocrystal for ocular drug delivery: hope or hype.
    Sharma OP; Patel V; Mehta T
    Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium.
    Luo Z; Jin L; Xu L; Zhang ZL; Yu J; Shi S; Li X; Chen H
    Drug Deliv; 2016; 23(1):63-8. PubMed ID: 24758189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.
    Irimia T; Dinu-Pîrvu CE; Ghica MV; Lupuleasa D; Muntean DL; Udeanu DI; Popa L
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30304825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smart stimuli-responsive chitosan hydrogel for drug delivery: A review.
    Tian B; Liu J
    Int J Biol Macromol; 2023 Apr; 235():123902. PubMed ID: 36871689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle.
    Gulsen D; Chauhan A
    Int J Pharm; 2005 Mar; 292(1-2):95-117. PubMed ID: 15725557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overview of biopolymers as carriers of antiphlogistic agents for treatment of diverse ocular inflammations.
    Sharma AK; Arya A; Sahoo PK; Majumdar DK
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():779-791. PubMed ID: 27287177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
    Fernández-Ferreiro A; González Barcia M; Gil-Martínez M; Vieites-Prado A; Lema I; Argibay B; Blanco Méndez J; Lamas MJ; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2015 Aug; 94():342-51. PubMed ID: 26079831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical ocular drug delivery systems: Innovations for an unmet need.
    Yang Y; Lockwood A
    Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review.
    Osi B; Khoder M; Al-Kinani AA; Alany RG
    Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanocomposite hydrogels: an optimistic insight towards the treatments of ocular disorders.
    Shah S; Patel R; Patel G
    Recent Pat Nanotechnol; 2023 Jul; ():. PubMed ID: 37519202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
    Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
    Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prominence of the dosage form design to treat ocular diseases.
    Campos PM; Petrilli R; Lopez RFV
    Int J Pharm; 2020 Aug; 586():119577. PubMed ID: 32622806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydrogel beads-based nanocomposites in novel drug delivery platforms: Recent trends and developments.
    Amiri M; Khazaeli P; Salehabadi A; Salavati-Niasari M
    Adv Colloid Interface Sci; 2021 Feb; 288():102316. PubMed ID: 33387892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
    George A; Shah PA; Shrivastav PS
    Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gamut of perspectives, challenges, and recent trends for in situ hydrogels: a smart ophthalmic drug delivery vehicle.
    Das B; Chattopadhyay D; Rana D
    Biomater Sci; 2020 Sep; 8(17):4665-4691. PubMed ID: 32760957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.